Evaluating the cost-benefit profile of CPI stem cell therapy requires a comprehensive approach. Advocates often emphasize the possibility for significant therapeutic gains, particularly in diseases where conventional medications have proven limited. However, this is to consider the significant financial expenditure associated with CPI stem cell the